WallStreetZenWallStreetZen

NASDAQ: GERN
Geron Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GERN

Based on 2 analysts offering 12 month price targets for Geron Corp

Min Forecast
$1.00-23.66%
Avg Forecast
$2.50+90.84%
Max Forecast
$4.00+205.34%

Should I buy or sell GERN stock?

Based on 2 analysts offering ratings for Geron Corp.

Sell
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 50%
Although GERN's forecast from analysts indicates a "Sell", our proven Zen Rating quant model rates GERN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GERN stock forecasts and price targets.

GERN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-05
lockedlocked$00.00+00.00%2025-07-10

1 of 1

Forecast return on equity

Is GERN forecast to generate an efficient return?

Company
10.47%
Industry
259.27%
Market
228.52%
GERN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GERN forecast to generate an efficient return on assets?

Company
4.59%
Industry
90.14%
GERN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GERN earnings per share forecast

What is GERN's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$0.12
Avg 2 year Forecast
-$0.08
Avg 3 year Forecast
$0.03

GERN revenue forecast

What is GERN's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$190.4M+3.84%
Avg 2 year Forecast
$264.9M+44.45%
Avg 3 year Forecast
$385.6M+110.27%
GERN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GERN revenue growth forecast

How is GERN forecast to perform vs Biotechnology companies and vs the US market?

Company
27.17%
Industry
102.02%
Market
25.67%
GERN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GERN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GERN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GERN$1.31$2.50+90.84%Sell
MPLT$18.49$31.00+67.66%Strong Buy
REPL$10.61$10.57-0.37%Buy
CRMD$10.56$18.40+74.24%Buy
KALV$16.43$25.75+56.73%Buy
View Top Biotech Stocks

Geron Stock Forecast FAQ

Is Geron Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: GERN) stock is to Sell GERN stock.

Out of 2 analysts, 0 (0%) are recommending GERN as a Strong Buy, 1 (50%) are recommending GERN as a Buy, 0 (0%) are recommending GERN as a Hold, 0 (0%) are recommending GERN as a Sell, and 1 (50%) are recommending GERN as a Strong Sell.

If you're new to stock investing, here's how to buy Geron stock.

What is GERN's earnings growth forecast for 2025-2027?

(NASDAQ: GERN) Geron's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.88%.

Geron's earnings in 2025 is -$79,990,000.On average, 9 Wall Street analysts forecast GERN's earnings for 2025 to be -$73,793,870, with the lowest GERN earnings forecast at -$75,070,580, and the highest GERN earnings forecast at -$67,027,304. On average, 9 Wall Street analysts forecast GERN's earnings for 2026 to be -$53,174,994, with the lowest GERN earnings forecast at -$100,094,107, and the highest GERN earnings forecast at -$20,108,191.

In 2027, GERN is forecast to generate $16,278,060 in earnings, with the lowest earnings forecast at -$62,558,817 and the highest earnings forecast at $107,243,686.

What is GERN's revenue growth forecast for 2025-2027?

(NASDAQ: GERN) Geron's forecast annual revenue growth rate of 27.17% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.02%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.67%.

Geron's revenue in 2025 is $183,403,000.On average, 9 Wall Street analysts forecast GERN's revenue for 2025 to be $121,568,378,571, with the lowest GERN revenue forecast at $115,797,646,885, and the highest GERN revenue forecast at $125,902,810,888. On average, 9 Wall Street analysts forecast GERN's revenue for 2026 to be $169,113,079,453, with the lowest GERN revenue forecast at $147,211,109,968, and the highest GERN revenue forecast at $196,243,178,641.

In 2027, GERN is forecast to generate $246,175,328,251 in revenue, with the lowest revenue forecast at $186,827,438,334 and the highest revenue forecast at $294,186,028,484.

What is GERN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: GERN) forecast ROA is 4.59%, which is lower than the forecast US Biotechnology industry average of 90.14%.

What is GERN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GERN price target, the average GERN price target is $2.50, with the highest GERN stock price forecast at $4.00 and the lowest GERN stock price forecast at $1.00.

On average, Wall Street analysts predict that Geron's share price could reach $2.50 by Nov 5, 2026. The average Geron stock price prediction forecasts a potential upside of 90.84% from the current GERN share price of $1.31.

What is GERN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GERN) Geron's current Earnings Per Share (EPS) is -$0.12. On average, analysts forecast that GERN's EPS will be -$0.12 for 2025, with the lowest EPS forecast at -$0.12, and the highest EPS forecast at -$0.11. On average, analysts forecast that GERN's EPS will be -$0.08 for 2026, with the lowest EPS forecast at -$0.16, and the highest EPS forecast at -$0.03. In 2027, GERN's EPS is forecast to hit $0.03 (min: -$0.10, max: $0.17).

What is GERN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: GERN) forecast ROE is 10.47%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.